Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Au nanostructures by colloidal lithography: from quenching to extensive fluorescence enhancement.

Journal of materials chemistry. B·2020
Same author

PEEK Composites as Self-Lubricating Bush Materials for Articulating Revolute Pin Joints.

Polymers·2020
Same author

Circular RNA CircHIPK3 Promotes Gemcitabine Sensitivity in Bladder Cancer.

Journal of Cancer·2020
Same author

Differential Abilities of Mammalian Cathelicidins to Inhibit Bacterial Biofilm Formation and Promote Multifaceted Immune Functions of Neutrophils.

International journal of molecular sciences·2020
Same author

Decreased striatal vesicular monoamine transporter 2 (VMAT2) expression in a type 1 diabetic rat model: A longitudinal study using micro-PET/CT.

Nuclear medicine and biology·2020
Same author

Maturation of topological organization of brain networks in male adolescent rats: A longitudinal FDG-PET study.

Neuroscience letters·2020
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Correlates and predictors of self-efficacy among dementia caregivers: D-CARE findings.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Primary cilia-extracellular vesicle crosstalk in Alzheimer's disease: Emerging mechanisms and biomarker potential.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Xinyi Lyu1, Feng Gao2, Xiaodong Pan3

  • 1Department of Neurology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

这项研究比较了中国阿尔茨海默病 (AD) 检测的血液生物标志物,评估了它们与PET扫描的准确性. 这些发现将有助于利用可靠的血液检测优化早期AD查.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经学 神经学
  • 生物标志物发现发现
  • 医学诊断 医学诊断 医学诊断

背景情况:

  • 阿尔茨海默病 (AD) 诊断依赖于侵入性方法,血液生物标志物显示出有希望但缺乏标准化检测.
  • 目前血液生物标志物检测的不一致性阻碍了AD查和诊断的广泛临床应用.

研究的目的:

  • 为了进行商业上可用的血液生物标志物的对比比较,用于阿尔茨海默病 (AD) 检测.
  • 评估血生物标志物 (Aβ40,Aβ42,t-tau,p-tau) 的灵敏度和特异性,以预测由Aβ-PET证实的粉样蛋白病理.
  • 在中国人口中优化AD查和诊断的临床途径.

主要方法:

  • CLEAR-AD研究是中国的一项横截面研究,涉及400名不同认知状态 (认知正常,MCI,痴呆) 的参与者.
  • 参与者接受了粉样蛋白位子发射断层扫描 (Aβ-PET) 扫描.
  • 使用各种检测方法 (例如单分子免疫检测,数字免疫检测芯片) 在盲目的条件下测量等离子体生物标志物,并与Aβ-PET结果进行比较.

主要成果:

  • 该研究评估了血生物标志物的诊断准确性与Aβ-PET作为参考标准.
  • 接收器操作特征 (ROC) 曲线被生成以确定生物标志物检测的最佳切断值.
  • 开发了一个整合多个生物标志物和临床数据的预测模型,以提高诊断能力.

结论:

  • 这项CLEAR-AD研究提供了关于商业血液生物标志物对预测阿尔茨海默病 (AD) 粉样蛋白病理学的性能的基本数据.
  • 这些发现将有助于优化早期AD查策略,特别是在中国人群中.
  • 预计这些结果将指导开发更有效的AD诊断工具.